Nurse Practitioner Program year 2023 Source: CMS Open Payments, 2026 publication

Catherine Toro-McCue

Registered Nurse, Psychiatric/Mental Health, Adult Boston, MA Nurse Practitioner

NPI 1659907343 CMS profile 11104435

800 Washington St, Boston, MA 02108

Open in the dashboard

General payments

$485

4 records reported · program year 2023

Research payments

$0

Paid to them · None reported · program year 2023

Ownership & investment interest

$0

None reported

Through program year 2023, Catherine Toro-McCue of Boston, MA is reported in the CMS Open Payments database as having received $485 across 4 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Registered Nurse, Psychiatric/Mental Health, Adult profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2023 General $485 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Catherine Toro-McCue
  • Registered Nurse, Psychiatric/Mental Health, Adult median
  • Middle half of Registered Nurse, Psychiatric/Mental Health, Adult
  • National median

In program year 2025, general payments to Catherine Toro-McCue were reported at $0. Among 96 Registered Nurse, Psychiatric/Mental Health, Adult profiles paid that year, the median was $121 and the middle half received between $39 and $265.

Show as a table
Year Catherine Toro-McCue Registered Nurse, Psychiatric/Mental Health, Adult median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $108 $31–$328 $132
2022 $0 $99 $22–$306 $149
2023 $485 $99 $43–$313 $160
2024 $0 $119 $30–$319 $164
2025 $0 $121 $39–$265 $169

Breakdown

Who paid General payments · program year 2023
  1. Janssen Pharmaceuticals, Inc $272 2 payments
  2. ITI, Inc. $213 2 payments

Every payment, record by record

What the payments were for General payments · program year 2023
  1. Food and Beverage $385 3 payments
  2. Education $100 1 payment
Products named General payments · program year 2023
  1. INVEGA SUSTENNA $272 2 payments
  2. CAPLYTA $213 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 34 drugs

Part D claims

1,499

Median for Registered Nurse: 109

Drug cost

$37,376

Median for Registered Nurse: $4,454

Branded share of claims

7.3%

Median for Registered Nurse: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lurasidone Hcl Generic 14 $16,716
Aripiprazole Generic 32 $2,258
Clonazepam Generic 303 $1,752
Risperidone Generic 29 $1,565
Quetiapine Fumarate Generic 97 $1,270
Chlorpromazine Hcl Generic 12 $1,212
Ziprasidone Hcl Generic 17 $1,035
Olanzapine Generic 59 $1,029
Fluoxetine Hcl Generic 113 $919
Mirtazapine Generic 67 $883

The 10 drugs with the highest cost, of 34 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 476 Part D prescribers listed as Registered Nurse; they describe a distribution and say nothing about conduct.

Records

4 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse, Psychiatric/Mental Health, Adult in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record